BioMarin Pharmaceutical (BMRN.O) is an international producer of innovative biopharmaceuticals for rare genetic diseases. The company’s developments provide significant advances for patients with rare, life-threatening diagnoses. BioMarin introduces new treatments to the market, providing enormous help to adults and children with serious inherited conditions that have few treatment options. Lately, the company has been named as one of the fastest developers of medicines. Τελευταία άρθρα για μετοχές